MA39397A1 - Human antibodies against monoclonal peak protein of mid-east respiratory syndrome coronavirus - Google Patents
Human antibodies against monoclonal peak protein of mid-east respiratory syndrome coronavirusInfo
- Publication number
- MA39397A1 MA39397A1 MA39397A MA39397A MA39397A1 MA 39397 A1 MA39397 A1 MA 39397A1 MA 39397 A MA39397 A MA 39397A MA 39397 A MA39397 A MA 39397A MA 39397 A1 MA39397 A1 MA 39397A1
- Authority
- MA
- Morocco
- Prior art keywords
- antibodies
- mers
- peak protein
- cov
- bind
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La présente invention concerne des anticorps monoclonaux qui se lient à la protéine de pic monoclonal du coronavirus du syndrome respiratoire du moyen-orient (mers-cov), ainsi que les méthodes d'utilisation de ceux-ci. Dans plusieurs modes de réalisation de l'invention, les anticorps sont des anticorps complètement humains qui se lient à la protéine de pic monoclonal du mers-cov. Dans certains modes de réalisation, les anticorps de l'invention peuvent servir à inhiber ou neutraliser l'activité du mers-cov, offrant ainsi un moyen de traitement ou de prévention d'une infection à mers chez l'homme. Dans certains modes de réalisation, l'invention fournit une association d'un ou de plusieurs anticorps qui se lient à la protéine de pic monoclonal du mers-cov, utilisables dans le traitement d'une infection à mers. Dans certains modes de réalisation, les anticorps unique ou multiples se lient à des épitopes distincts et non-concurrents appartenant au domaine de liaison du récepteur de la protéine de pic monoclonal du mers-cov.The present invention relates to monoclonal antibodies that bind to the mid-east respiratory syndrome coronavirus (mers-cov) monoclonal peak protein, as well as methods of use thereof. In several embodiments of the invention, the antibodies are fully human antibodies that bind to the mers-cov monoclonal peak protein. In some embodiments, the antibodies of the invention may be used to inhibit or neutralize mers-cov activity, thereby providing a means for treating or preventing human infection in humans. In some embodiments, the invention provides a combination of one or more antibodies that bind to the mers-cov monoclonal peak protein, useful in the treatment of an infection at sea. In some embodiments, the single or multiple antibodies bind to distinct and non-competing epitopes belonging to the mers-cov monoclonal peak protein receptor binding domain.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462002233P | 2014-05-23 | 2014-05-23 | |
PCT/US2015/031800 WO2015179535A1 (en) | 2014-05-23 | 2015-05-20 | Human antibodies to middle east respiratory syndrome -coronavirus spike protein |
Publications (1)
Publication Number | Publication Date |
---|---|
MA39397A1 true MA39397A1 (en) | 2018-03-30 |
Family
ID=62203545
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA56083A MA56083B1 (en) | 2014-05-23 | 2015-05-20 | HUMAN ANTIBODIES AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS MONOCLONAL PIC PROTEIN |
MA39397A MA39397A1 (en) | 2014-05-23 | 2015-05-20 | Human antibodies against monoclonal peak protein of mid-east respiratory syndrome coronavirus |
MA50737A MA50737B1 (en) | 2014-05-23 | 2016-10-20 | Human Antibodies Against Middle East Respiratory Syndrome Coronavirus Monoclonal Spike Protein |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA56083A MA56083B1 (en) | 2014-05-23 | 2015-05-20 | HUMAN ANTIBODIES AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS MONOCLONAL PIC PROTEIN |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA50737A MA50737B1 (en) | 2014-05-23 | 2016-10-20 | Human Antibodies Against Middle East Respiratory Syndrome Coronavirus Monoclonal Spike Protein |
Country Status (1)
Country | Link |
---|---|
MA (3) | MA56083B1 (en) |
-
2015
- 2015-05-20 MA MA56083A patent/MA56083B1/en unknown
- 2015-05-20 MA MA39397A patent/MA39397A1/en unknown
-
2016
- 2016-10-20 MA MA50737A patent/MA50737B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA50737B1 (en) | 2023-03-31 |
MA56083A1 (en) | 2023-04-28 |
MA50737A1 (en) | 2021-12-31 |
MA56083B1 (en) | 2023-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA44312A (en) | ANTIBODIES AND THEIR METHODS OF USE | |
EA201691877A1 (en) | HUMAN ANTIBODIES TO THE SPIKE PROTEIN OF THE MIDDLE EASTERN RESPIRATORY SYNDROME CORONAVIRUS | |
PH12017502358A1 (en) | Factor xi antibodies and methods of use | |
MA40497A (en) | ANTIBODIES AND CHEMERICAL ANTIGENIC RECEPTORS SPECIFIC TO CD19 | |
CR10068A (en) | ANTI MN ANTIBODIES AND METHODS FOR USE | |
MA40041A (en) | ANTI-GITR ANTIBODIES AND THEIR METHODS OF USE | |
UA109633C2 (en) | HUMAN ANTIBODY AGAINST TISSUE FACTOR | |
EA201070636A1 (en) | INHIBITION OF THE PROTECTOR PROTEIN, STIMULATING MACROPHAGE (RON), AND METHODS OF ITS TREATMENT | |
EA202090204A1 (en) | ANTI-CD137 ANTIBODIES | |
EA201270662A1 (en) | BINDING ELEMENTS FOR HUMAN CYTAMEGALOVIRUS | |
MA37761A1 (en) | Proteins for binding to a double receptor antagonist antigen and their uses | |
EA201390813A1 (en) | ANTIBODIES AND THEIR APPLICATION | |
EA202191175A1 (en) | CYSTEINE-DESIGNED ANTIBODY-DRUG CONJUGATES CONTAINING PEPTIDE-CONTAINING LINKERS | |
MX2021001902A (en) | Antibodies binding to citrullinated histone 2a and/or 4. | |
EA202190138A1 (en) | ANTI-SIRP-BETA1 ANTIBODIES AND METHODS OF THEIR USE | |
EA202092085A1 (en) | THERAPEUTIC ANTIBODIES AGAINST sPLA2-GIB AND THEIR APPLICATION | |
ATE472998T1 (en) | CATIONIC LIPOSOMAL PREPARATIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | |
EA200702634A1 (en) | HUMANIZED ANTIBODIES SPECIFIC FOR NOGO-A AND THEIR PHARMACEUTICAL APPLICATIONS | |
EA202191058A1 (en) | ANTIBODIES AGAINST MUCIN-16 AND METHODS OF THEIR APPLICATION | |
EA202090944A1 (en) | ANTI-CD3-ANTIBODY AND A PHARMACEUTICAL COMPOSITION FOR TREATING ONCOLOGICAL DISEASES, CONTAINING IT | |
EA202092265A1 (en) | ANTIBODIES AGAINST CD137 FOR COMBINATION WITH ANTIBODIES AGAINST PD-L1 | |
MA39397A1 (en) | Human antibodies against monoclonal peak protein of mid-east respiratory syndrome coronavirus | |
MX2020013923A (en) | Anti-l1cam antibodies and uses thereof. | |
EA202092981A1 (en) | ANTIBODIES TO L1CAM AND THEIR APPLICATION | |
MA47976B1 (en) | ANTIBODIES DIRECTED AGAINST TREM2 AND THEIR USE |